Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical Tranexamic Acid vs Topical Ethyl Ascorbic Acid in Melasma
NCT07522788Phase 4Not yet recruiting
- Sponsor
- Hayatabad Medical Complex
- Start
- Jun 2026
- Primary completion
- Nov 2026
- Modality
- Small Molecules
01
Overview
A Phase 4 trial of ethyl ascorbic acid in melasma, sponsored by Hayatabad Medical Complex. Planned start Jun 2026; status: not yet recruiting.
02
Drugs
ethyl ascorbic acid
03
Conditions
melasma
Beyond the preview
Go deeper on NCT07522788.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07522788.